These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Müller N; Schwarz MJ Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312 [TBL] [Abstract][Full Text] [Related]
11. The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment. Müller N; Myint AM; Schwarz MJ Dialogues Clin Neurosci; 2009; 11(3):319-32. PubMed ID: 19877499 [TBL] [Abstract][Full Text] [Related]
12. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. Steiner J; Bogerts B; Sarnyai Z; Walter M; Gos T; Bernstein HG; Myint AM World J Biol Psychiatry; 2012 Oct; 13(7):482-92. PubMed ID: 21707463 [TBL] [Abstract][Full Text] [Related]
13. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Müller N; Schwarz MJ Eur Arch Psychiatry Clin Neurosci; 2008 Jun; 258 Suppl 2():97-106. PubMed ID: 18516521 [TBL] [Abstract][Full Text] [Related]
15. Immunological aspects of the treatment of depression and schizophrenia. Müller N Dialogues Clin Neurosci; 2017 Mar; 19(1):55-63. PubMed ID: 28566947 [TBL] [Abstract][Full Text] [Related]
17. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis. Ramírez LA; Pérez-Padilla EA; García-Oscos F; Salgado H; Atzori M; Pineda JC Biomedica; 2018 Sep; 38(3):437-450. PubMed ID: 30335249 [TBL] [Abstract][Full Text] [Related]